- Home
- KPRX vs EJH Comparison
KPRX vs EJH Comparison
Compare KPRX & EJH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- EJH
- Stock Information
- Founded
- KPRX 1998
- EJH 2018
- Country
- KPRX United States
- EJH China
- Employees
- KPRX N/A
- EJH N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EJH Other Consumer Services
- Sector
- KPRX Health Care
- EJH Consumer Discretionary
- Exchange
- KPRX Nasdaq
- EJH Nasdaq
- Market Cap
- KPRX 8.6M
- EJH 9.5M
- IPO Year
- KPRX N/A
- EJH 2021
- Fundamental
- Price
- KPRX $2.99
- EJH $1.61
- Analyst Decision
- KPRX Strong Buy
- EJH
- Analyst Count
- KPRX 1
- EJH 0
- Target Price
- KPRX $10.00
- EJH N/A
- AVG Volume (30 Days)
- KPRX 62.4K
- EJH 438.3K
- Earning Date
- KPRX 08-08-2025
- EJH 01-01-0001
- Dividend Yield
- KPRX N/A
- EJH N/A
- EPS Growth
- KPRX N/A
- EJH N/A
- EPS
- KPRX N/A
- EJH N/A
- Revenue
- KPRX $20,000.00
- EJH $50,110,199.00
- Revenue This Year
- KPRX N/A
- EJH N/A
- Revenue Next Year
- KPRX N/A
- EJH N/A
- P/E Ratio
- KPRX N/A
- EJH N/A
- Revenue Growth
- KPRX N/A
- EJH N/A
- 52 Week Low
- KPRX $2.51
- EJH $0.96
- 52 Week High
- KPRX $4.80
- EJH $775.00
- Technical
- Relative Strength Index (RSI)
- KPRX 47.28
- EJH 28.79
- Support Level
- KPRX $2.96
- EJH $0.96
- Resistance Level
- KPRX $3.29
- EJH $3.03
- Average True Range (ATR)
- KPRX 0.15
- EJH 0.49
- MACD
- KPRX 0.01
- EJH 0.12
- Stochastic Oscillator
- KPRX 38.78
- EJH 19.17
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About EJH E-Home Household Service Holdings Limited
E-Home Household Service Holdings Ltd is a household service company providing integrated household services through its website and WeChat platform across China. The company offers services including home appliance and housekeeping services. It operates its business mainly by receiving the orders online and providing the services offline. Its operations are organized into five reportable segments: installation and maintenance services, housekeeping services, senior care services, sales of pharmaceutical products and educational consulting services. The group's principal source of revenue comes from the Installation and Maintenance segment, followed by Housekeeping and Senior care services segment.